Kaushal Parikh

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Kaushal Parikh

Sep 24, 2024, 13:32 | Insight

Jarushka Naidoo: Stage III ALK+ NSCLC - consolidation ALK TKI vs Durvalumab vs Observation

Jarushka Naidoo shared on X: "Stage III ALK+ NSCLC: consolidation ALK Tyrosine Kinase Inhibitors versus…

Jun 11, 2024, 11:53 | Societies

Mayo Clinic and American Hospital Dubai will host the fifth annual International Oncology Summit in Dubai

Mayo Clinic recently shared a post on LinkedIn: "Mayo Clinic and American Hospital Dubai, a…

Feb 7, 2024, 12:46 | Blog

Amin Nassar presents the results of a multicenter retrospective cohort for osimertinib and durvalumab in unresectable EGFR-mutant NSCLC

Amin Nassar, Hematology/Oncology Fellow at Yale University, shared a post on X/Twitter: "1. Pumped to…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023